Syra Health Corp.
SYRA
$0.3401
-$0.0189-5.27%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.74M | 7.07M | 6.08M | 5.52M | 5.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.74M | 7.07M | 6.08M | 5.52M | 5.71M |
| Cost of Revenue | 5.96M | 5.40M | 4.64M | 4.11M | 4.60M |
| Gross Profit | 1.78M | 1.67M | 1.44M | 1.41M | 1.11M |
| SG&A Expenses | 5.13M | 4.98M | 4.43M | 4.01M | 3.57M |
| Depreciation & Amortization | 67.80K | 54.70K | 49.60K | 48.90K | 46.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.99M | 11.23M | 9.64M | 8.40M | 8.22M |
| Operating Income | -4.25M | -4.16M | -3.56M | -2.89M | -2.50M |
| Income Before Tax | -4.25M | -4.19M | -3.60M | -2.94M | -2.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.25 | -4.19 | -3.60 | -2.94 | -2.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.25M | -4.19M | -3.60M | -2.94M | -2.56M |
| EBIT | -4.25M | -4.16M | -3.56M | -2.89M | -2.50M |
| EBITDA | -4.18M | -4.11M | -3.51M | -2.84M | -2.46M |
| EPS Basic | -0.65 | -0.67 | -0.64 | -0.60 | -0.56 |
| Normalized Basic EPS | -0.40 | -0.42 | -0.40 | -0.38 | -0.35 |
| EPS Diluted | -0.65 | -0.67 | -0.64 | -0.60 | -0.56 |
| Normalized Diluted EPS | -0.40 | -0.42 | -0.40 | -0.38 | -0.35 |
| Average Basic Shares Outstanding | 26.73M | 23.83M | 21.61M | 19.46M | 18.24M |
| Average Diluted Shares Outstanding | 26.73M | 23.83M | 21.61M | 19.46M | 18.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
